BRS6-FM3-PM7 — Vagal Tone / HRV Regulation
Stage 2B draft — not approved. Independent Stage 2A/2B preview. Canonical science, mappings, ratings and review status are unchanged.
1. Mission & Overview
Mission
Sustain vagal tone so heart-rate-variability-linked recovery signalling remains robust under repeated stress exposure.
Intervention Dominance: Lifestyle-Dominant — System Optimisation Practices
Inherited qualification requires final scientific approval. Biological requirements alone do not establish responsiveness or comparative dominance. No head-to-head comparative supremacy is established. Other admitted routes remain in section 3; absence of an admission is not inferiority.
- Slow-paced breathing at six cycles per minute
- EPA+DHA supplementation (studied combined formulation)
Overview
The vagus nerve helps regulate the heart’s response to demand. Heart-rate variability, the changing interval between beats, provides one window onto cardiac regulation when breathing and measurement conditions are considered. Paced breathing can change this signal during a session. An omega-3 trial also found changes in adults with elevated triglycerides. These findings make cardiac regulation addressable, while requiring a clear distinction between measured HRV and the wider functions of the vagus. Sauder et al. (2013) [1]; You et al. (2021) [5]
- Benefits: Responsive cardiac regulation contributes to recovery physiology, with HRV used as a context-dependent measure. You et al. (2021) [5]
- Implementation Notes: Slow-paced breathing at six cycles per minute was studied for five to twenty minutes; longer was not consistently better. Sauder et al. (2013) [1]; You et al. (2021) [5]
- Biological Relevance: Higher session HRV does not establish stronger whole-body vagal function or lasting recovery.
2. Primary Biological Effects
- Slow-paced breathing increased RMSSD during the session relative to control. You et al. (2021) [5]
- The higher-dose EPA+DHA condition increased RMSSD and total power relative to placebo. Sauder et al. (2013) [1]
3. Intervention Levers
No independently admitted Direct/Derived Dietary Requirements established in this draft.
No additional separately adjudicated biochemical requirement established in this draft; generic metabolic participation is not an admitted PM-specific requirement.
No mapping established.
No separately adjudicated Lifestyle Lever is admitted in this draft.
4. Mechanistic Basis
Summary
Slow-paced breathing increased RMSSD during the session relative to control. You et al. (2021) [5]
Biological process
The cardiac proxy was responsive; post-session persistence and general vagal function remain different questions. You et al. (2021) [5]
Mechanism Boundary
Higher session HRV does not establish stronger whole-body vagal function or lasting recovery. The draft preserves each source’s measured endpoint; the Mission describes the biological job and does not assert that every tested lever achieved the entire Mission.
Integration
This PM contributes its specified process to BRS6(FM3). Shared fuels, nutrient lists and correlated markers do not merge distinct biological jobs or establish the integrated outcome.
4.1 Scientific Findings
Summary
Slow breathing produced a during-session HRV effect without a duration gradient or established persistent change. EPA+DHA altered HRV in a specific metabolic population. The student anxiety/inflammation trial did not measure vagal tone. Sauder et al. (2013) [1]; You et al. (2021) [5]
Slow-paced breathing increased RMSSD during the session relative to control.
What this means
The cardiac proxy was responsive; post-session persistence and general vagal function remain different questions.
Evidence confidence: Not yet scored
Finding ID: PM7-F1
Finding Statement: Slow-paced breathing increased RMSSD during the session relative to control.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The cardiac proxy was responsive; post-session persistence and general vagal function remain different questions.
Synthesis Limitations: Young adults; respiration directly influences HRV interpretation.
Evidence Considered:
- Study
- Fifty-nine young adults; randomized visits with six-cycle breathing for 5–20 minutes and control.
- Population
- Fifty-nine young adults; randomized visits with six-cycle breathing for 5–20 minutes and control.
- Result
- During-session RMSSD increased without a significant duration gradient.
- Effect / Magnitude
- Only source-extracted comparisons retained; no pooled benefit estimate.
- Evidence Summary
- During-session RMSSD increased without a significant duration gradient.
- Limitations
- No established lasting elevation after the practice.
- Evidence Source
- Bounded external search
- Reference
- [5]
Connected / Supportive Evidence:
- Austelle et al. (2022) [2]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: Clinical electrical vagus stimulation is not an independently established food or ordinary lifestyle relationship.
- Kiecolt-Glaser et al. (2011) [3]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: Stimulated systemic immune-cell cytokines and anxiety; not adipose-specific signalling or a distinct HRV nutrient requirement.
- Lane et al. (2010) [4]Why relevant: Preserved attached corpus, assessed for the mission-specific endpoint rather than inherited as an admission.Why excluded from the primary synthesis: The attached source is contextual. No separately extracted mission-specific intermediary or intervention endpoint justifies a new requirement, KC admission or phenome rating from this source.
The higher-dose EPA+DHA condition increased RMSSD and total power relative to placebo.
What this means
This is an intervention observation, not an indispensable vagal nutrient requirement.
Evidence confidence: Not yet scored
Finding ID: PM7-F2
Finding Statement: The higher-dose EPA+DHA condition increased RMSSD and total power relative to placebo.
Synthesised Evidence Confidence: Not yet scored
Synthesis: This is an intervention observation, not an indispensable vagal nutrient requirement.
Synthesis Limitations: Elevated-triglyceride adults, combined formulation; constituent effects not isolated.
Evidence Considered:
- Study
- Twenty-six adults, crossover 0.85 or 3.4 g/day EPA+DHA versus placebo for eight weeks.
- Population
- Twenty-six adults, crossover 0.85 or 3.4 g/day EPA+DHA versus placebo for eight weeks.
- Result
- Higher-dose HRV measures increased; mood did not provide a generalized outcome claim.
- Effect / Magnitude
- Only source-extracted comparisons retained; no pooled benefit estimate.
- Evidence Summary
- Higher-dose HRV measures increased; mood did not provide a generalized outcome claim.
- Limitations
- Exact combined supplement and study context, not food equivalence.
- Evidence Source
- Bounded external search
- Reference
- [1]
5. BRS Pathways and Connections
5.1 BRS Pathways
No newly adjudicated BRS pathway is added by this preview.
5.2 Cross-BRS Mechanism Relationships
No downstream mapping is inherited from a shared nutrient or KC candidate.
5.3 Local BRS Mechanism Relationships
PM6 addresses recovery after activation; a respiration-sensitive HRV rise does not prove recovery of all autonomic branches.
7. Phenome Connections
No new phenome rating is admitted by this unapproved preview. Inherited candidates are retained in the structured assessment history; biomarker or neural changes do not automatically demonstrate a cognitive outcome.
8. References
- [1] Sauder et al. (2013) — Effects of Omega-3 Fatty Acid Supplementation on Heart Rate Variability At Rest
- [2] Austelle et al. (2022) — A Comprehensive Review of Vagus Nerve Stimulation for Depression
- [3] Kiecolt-Glaser et al. (2011) — A Randomized Controlled Trial
- [4] Lane et al. (2010) — Differentiating Using Electrodermal Responses, Cortisol, and Anxiety
- [5] You et al. (2021) — Single Slow-Paced Breathing Session at Six Cycles per Minute: Investigation of Dose-Response Relationship on Cardiac Vagal Activity